OptimizeRx (NASDAQ:OPRX) Price Target Lowered to $8.00 at JMP Securities
OptimizeRx (NASDAQ:OPRX – Free Report) had its target price decreased by JMP Securities from $16.00 to $8.00 in a research report report published on Thursday morning,Benzinga reports. JMP Securities currently has a market outperform rating on the stock. Other analysts have also recently issued research reports about the stock. Barclays dropped their target price on […]
More Stories
indie Semiconductor, Inc. (NASDAQ:INDI) CEO Donald Mcclymont Sells 50,000 Shares
indie Semiconductor, Inc. (NASDAQ:INDI – Get Free Report) CEO Donald Mcclymont sold 50,000 shares of the stock in a transaction...
Tactical Advantage ETF (NYSEARCA:FDAT) Plans $1.89 Dividend
Tactical Advantage ETF (NYSEARCA:FDAT – Get Free Report) announced a dividend on Tuesday, December 17th,NASDAQ Dividends reports. Investors of record...
Matthews China Discovery Active ETF Plans Annual Dividend of $1.41 (NASDAQ:MCHS)
Matthews China Discovery Active ETF (NASDAQ:MCHS – Get Free Report) declared an annual dividend on Tuesday, December 17th,NASDAQ Dividends reports....
Jorge Celaya Sells 16,540 Shares of Liquidity Services, Inc. (NASDAQ:LQDT) Stock
Liquidity Services, Inc. (NASDAQ:LQDT – Get Free Report) CFO Jorge Celaya sold 16,540 shares of the company’s stock in a...
Voyageur Pharmaceuticals (CVE:VM) Trading Up 50% – Time to Buy?
Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 50% during trading on Wednesday . The company traded...
Amplify Transformational Data Sharing ETF (NYSEARCA:BLOK) Hits New 1-Year High – Should You Buy?
Shares of Amplify Transformational Data Sharing ETF (NYSEARCA:BLOK – Get Free Report) hit a new 52-week high during trading on...